Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcium hypophosphite is an inorganic salt being investigated for its remineralizing properties in dental care. Developed by researchers associated with the Dr. Wolff Group, it is primarily formulated into toothpastes as a fluoride-free alternative for the prevention of dental caries. The compound acts as a source of calcium and phosphate ions, which are critical for the repair and maintenance of tooth enamel. By promoting the deposition of mineral phases onto demineralized tooth surfaces, calcium hypophosphite helps to restore enamel integrity and inhibit the progression of decay. It has been evaluated in large-scale clinical trials to demonstrate non-inferiority to standard fluoride-containing toothpastes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium hypophosphite.